LAB Act

10/28/2022, 1:45 AM

Laboratory Access for Beneficiaries Act or the LAB Act

This bill revises the periods during which laboratories must report clinical diagnostic test information to the Centers for Medicare & Medicaid Services for purposes of determining Medicare payment rates. Additionally, the Medicare Payment Advisory Commission must evaluate the methodology used to determine a specified laboratory fee schedule.

Congress
116

Number
S - 3049

Introduced on
2019-12-12

# Amendments
0

Sponsors
+5

Cosponsors
+5

Variations and Revisions

12/12/2019

Status of Legislation

Bill Introduced
Introduced to House
House to Vote
Introduced to Senate
Senate to Vote

Purpose and Summary

Laboratory Access for Beneficiaries Act or the LAB Act

This bill revises the periods during which laboratories must report clinical diagnostic test information to the Centers for Medicare & Medicaid Services for purposes of determining Medicare payment rates. Additionally, the Medicare Payment Advisory Commission must evaluate the methodology used to determine a specified laboratory fee schedule.

Alternative Names
Official Title as IntroducedA bill to amend title XVIII of the Social Security Act to provide for certain amendments relating to reporting requirements with respect to clinical diagnostic laboratory tests, and for other purposes.

Policy Areas
Health

Potential Impact
Congressional oversight
Drug safety, medical device, and laboratory regulation
Government information and archives
Government studies and investigations
Health care costs and insurance
Health information and medical records
Inflation and prices
Medical tests and diagnostic methods
Medicare

Comments

Recent Activity

Latest Summary10/9/2020

Laboratory Access for Beneficiaries Act or the LAB Act

This bill revises the periods during which laboratories must report clinical diagnostic test information to the Centers for Medicare & Medicaid Services for purposes of dete...


Latest Action12/12/2019
Read twice and referred to the Committee on Finance.